Similar articles

• Bioavailability of digoxin from tablets. III. Availability of digoxin in man from preparations with different dissolution rate.

  Nyberg L, Andersson KE, Bertler A. Nyberg L, et al. Acta Pharm Suec. 1974 Nov;11(5):471-92. Acta Pharm Suec. 1974. PMID: 4440505 No abstract available.
• Non-equivalence of digoxin tablets.

  Reissell P, Manninen V, Ojala K, Karjalainen J. Reissell P, et al. Ann Clin Res. 1974;6(0):suppl 11:4-8. Ann Clin Res. 1974. PMID: 4853359 No abstract available.
• [Clinical study of the biological availability of lanatoside C and digoxin in long-term tests].

  Bodem G, Ochs H, Hahn E, Dengler HJ. Bodem G, et al. Schweiz Med Wochenschr. 1977 May 14;107(19):658-66. Schweiz Med Wochenschr. 1977. PMID: 867012 German.
• Appraisal of digoxin bioavailability and pharmacokinetics in relation to cardiac therapy.

  Wagner JG. Wagner JG. Am Heart J. 1974 Aug;88(2):133-8. doi: 10.1016/0002-8703(74)90001-5. Am Heart J. 1974. PMID: 4601506 Review. No abstract available.
• Bioavailability of drugs: the digoxin dilemma.

  Greenblatt DJ, Smith TW, Koch-Weser J. Greenblatt DJ, et al. Clin Pharmacokinet. 1976;1(1):36-51. doi: 10.2165/00003088-197601010-00004. Clin Pharmacokinet. 1976. PMID: 797491 Review.